| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/16/2009 | CA2702008A1 Inhibitors of protein kinases |
| 04/16/2009 | CA2701868A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 04/16/2009 | CA2701865A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 04/16/2009 | CA2701057A1 Pyrrolo[2,3-d]pyrimidin derivatives as protein kinase b inhibitors |
| 04/16/2009 | CA2700713A1 Pyrrolopyrrole derivatives, their manufacture and use |
| 04/16/2009 | CA2696424A1 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 1 |
| 04/16/2009 | CA2696423A1 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 2 |
| 04/15/2009 | EP2048148A1 Methyl aquocobyrinic acid derivative, alkylation composition, and method for detoxifying harmful compound by utilizing the composition |
| 04/15/2009 | EP2048137A1 Benzamide derivatives and their use as glucokinase activating agents. |
| 04/15/2009 | EP2046794A1 Fungicidal azolopyrimidines, methods for the production thereof, use thereof for controlling harmful fungi, and substances containing the same |
| 04/15/2009 | EP2046793A2 Fused pyrimido compounds |
| 04/15/2009 | EP2046333A2 Thiozolidinedione derivatives as p13 kinase inhibitors |
| 04/15/2009 | EP2003104A9 Reagent for organic synthesis and method of organic synthesis reaction with the reagent |
| 04/15/2009 | EP1719773B1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor |
| 04/15/2009 | EP1689720B1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 04/15/2009 | EP1646633B1 Beta-strand mimetics |
| 04/15/2009 | EP1378246B1 sPLA2 INHIBITORS FOR ARTERIOSCLEROSIS |
| 04/15/2009 | CN101410400A Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 04/15/2009 | CN101410398A Improved process for producing carbapenem compound |
| 04/15/2009 | CN101410111A Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| 04/15/2009 | CN101407519A Method for synthesizing 5,6,7,8-tetrahydrochysene- imidazo [1,5-alpha] pyrazine |
| 04/15/2009 | CN101407489A 2-alkyl acrylate compounds and uses thereof |
| 04/15/2009 | CN101406471A Novel heterocyclic compounds which are active as inhibitors of beta-lactamases |
| 04/15/2009 | CN100478031C The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 04/14/2009 | US7518905 High density memory device |
| 04/14/2009 | US7517994 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/14/2009 | US7517904 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 04/14/2009 | US7517903 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indole-4-one (CBI) with incorporated alkylating domain; in vivo drug-cleavable substrate conjugates that are potent cytotoxins; antiproliferative, anticarcinogenic agent; leukemia; bone marrow and mucosal toxicity; chronic cardiac and neurological toxicity |
| 04/14/2009 | US7517883 Solubilized topoisomerase poisons |
| 04/14/2009 | US7517875 Piperidine derivatives having CCR3 antagonism |
| 04/14/2009 | US7517874 Substituted imidazo[1,5-a][1,4]diazepines and imidazo[1,5-a]pyrazines as cannabinoid receptor agonists for the treatment of pain |
| 04/14/2009 | US7517532 Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors |
| 04/14/2009 | CA2468658C [1,2,4]-triazole bicyclic adenosine a2a receptor antagonists |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/09/2009 | WO2009046004A1 Carboxamide gabaa alpha2 modulators |
| 04/09/2009 | WO2009044777A1 Oxazolidinone derivative having 7-membered hetero ring |
| 04/09/2009 | WO2009044007A2 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/09/2009 | WO2009043934A1 IMIDAZO[L,2-α]QUINOXALINES AND DERIVATIVES THEREOF FOR TREATING CANCERS |
| 04/09/2009 | WO2009016286A3 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 04/09/2009 | WO2008122667A3 Ureylene derivatives |
| 04/09/2009 | US20090093630 Chiral synthesis of diazepinoquinolines |
| 04/09/2009 | US20090093629 Process for preparation of triazol-benzodiazepine derivatives |
| 04/09/2009 | US20090093489 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 04/09/2009 | US20090093477 Tetrahydropyrrolopyrimidinediones and their use in therapy |
| 04/09/2009 | US20090093476 Pyrrolo[1,2-a]quinoxaline derivatives as adenosine a3 receptor modulators and uses thereof |
| 04/09/2009 | US20090093475 Oxo-substituted imidazo[1,2b]pyridazines, their preparation and use as pharmaceuticals |
| 04/09/2009 | US20090093466 Carboxamide GABAa ALPHA2 Modulators |
| 04/09/2009 | US20090093454 Chemical Compounds |
| 04/09/2009 | CA2701386A1 Imidazo[1,2-.alpha.]quinoxalines and derivatives thereof for treating cancers |
| 04/09/2009 | CA2700903A1 Parp inhibitor compounds, compositions and methods of use |
| 04/09/2009 | CA2694288A1 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/08/2009 | EP2044958A2 Pharmaceutical composition for treating arteriosclerosis |
| 04/08/2009 | EP2044074A2 Purinone derivatives as hm74a agonists |
| 04/08/2009 | EP2044073A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 04/08/2009 | EP2044072A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia |
| 04/08/2009 | EP2044071A1 OOXO-SUBSTITUTED IMIDAZO[1,2b]PYRIDAZINES, PRODUCTION AND USE THEREOF AS DRUGS |
| 04/08/2009 | EP2044054A2 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity |
| 04/08/2009 | EP2044033A1 A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles |
| 04/08/2009 | EP2043744A2 Chemical compounds |
| 04/08/2009 | EP2043655A2 Purine and deazapurine derivatives as pharmaceutical compounds |
| 04/08/2009 | EP1931671B1 Alkyl 4- [4- (5-oxo-2, 3, 5, 11a-tetrahyd0-5h-pyrr0l0 [2, 1-c][1, 4]benzodiazepine-8-yloxy) -butyrylamino]-1h-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative disease |
| 04/08/2009 | EP1877364B1 Phenylacetylene derivatives having mglur5 receptor affinity |
| 04/08/2009 | EP1389209B1 Folate mimetics and folate-receptor binding conjugates thereof |
| 04/08/2009 | EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 04/08/2009 | CN101405290A Polymorphs of Eszopiclone malate |
| 04/08/2009 | CN101405289A Pyrazolo[1,5-A]pyrimidine derivatives and methods of use thereof |
| 04/08/2009 | CN101405282A Aurora kinase modulators and method of use |
| 04/08/2009 | CN101402601A Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 04/08/2009 | CN100475822C Synthesis method for producing ecteinascidin compound |
| 04/08/2009 | CN100475817C Crystal of 1-methyl carbapenem compound |
| 04/08/2009 | CN100475816C Reverse-turn mimetics and method relating thereto |
| 04/07/2009 | US7514570 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (GnRH) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 04/07/2009 | US7514475 Benzylamine analogues |
| 04/07/2009 | US7514443 pyrazolo- and imidazo-pyrimidine derivatives; for anxiety and pain, neurodegenerative disorders; 8-Pyridin-4-yl-4-trifluoromethyl-2-(4-trifluoromethyl-phenyl)-imidazo[1,5-a]pyrimidine |
| 04/07/2009 | US7514442 Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/07/2009 | US7514441 Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents |
| 04/07/2009 | US7514440 angiogenesis inhibitors; as antitumor agents; kinase inhibitors like vascular endothelial growth factor receptors antagonists |
| 04/07/2009 | US7514435 Pyrrolotriazine kinase inhibitors |
| 04/07/2009 | US7514427 Aids therapy; viricides |
| 04/07/2009 | US7514422 To treat obesity, schizophrenia, anxiety, depression, alcoholism; using 3-benoazepine compounds like 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (lorcaserin); serotonin 2c receptor agonists |
| 04/07/2009 | CA2498291C Diazabicyclic compounds useful in the treatment of cns and other disorders |
| 04/07/2009 | CA2493633C Kinase inhibitors |
| 04/07/2009 | CA2463294C Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/07/2009 | CA2458684C Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 04/07/2009 | CA2393757C Cycloamine ccr5 receptor antagonists |
| 04/07/2009 | CA2341991C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 04/07/2009 | CA2341968C Pyrrolobenzodiazepine compounds |
| 04/07/2009 | CA2341471C Pyrrolbenzodiazepines |
| 04/07/2009 | CA2339253C Inhibitors of p38 |
| 04/02/2009 | WO2009042806A1 Polo-like kinase inhibitors |
| 04/02/2009 | WO2009042711A1 Polo-like kinase inhibitors |
| 04/02/2009 | WO2009042013A1 Process for the synthesis of e1 activating enzyme inhibitors |
| 04/02/2009 | WO2009041663A1 Agent for prevention and/or treatment of skin diseases |
| 04/02/2009 | WO2009041567A1 Diaryl ketimine derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 04/02/2009 | WO2009041475A1 Method for producing pyrazol-3-yl-benzamide derivative |
| 04/02/2009 | WO2009041456A1 Imidazopyridazine derivative |
| 04/02/2009 | WO2009040817A2 Salarins and tulearins, compositions and uses thereof |
| 04/02/2009 | WO2009040556A1 Pyrimidine derivatives as protein kinase inhibitors |
| 04/02/2009 | WO2009040411A1 Photodynamic therapy and diagnosis using a chlorin e4 zinc complex |
| 04/02/2009 | WO2009039635A1 Methods of modulating neurotrophin-mediated activity |